Epidemiology of Hepatitis
This hepatitis A infection is more dominantly seen in children between the ages 5-14 whatever it is rarely seen in infants. Apart from adults who exhibit serious clinical symptoms the children infected with the Hepatitis A shows mild symptoms only. However Hepatitis A infection is said to impose greater risk to some population groups such as persons suffering from clotting disorders, chronic liver dieses, and persons administering clotting factors. Hepatitis B is most common type of viral Hepatitis seen all over the world. Hepatitis B virus is predominantly found in East Asia, African and sub-Saharan regions. This Hepatitis B infection imposes more risk to persons with intravenous drug administrations, health care workers and people with abnormal sexual behaviour. Hepatitis C virus has less prevalence which can be 30% of the world population. This Hepatitis C viral infection can lead to serious conditions like hepatocellular carcinoma and cirrhosis. Hepatitis D virus spreads through the syringe needles and other mode of contact with the infected person. The geographical regions including United States and northern Europe are more prone to this infection. Hepatitis E spreads by weakening the immune system and is responsible for nearly 55,000 deaths per annum.
Related Conference of Epidemiology of Hepatitis
5th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
17th International Conference on Chronic Obstructive Pulmonary Disease
Epidemiology of Hepatitis Conference Speakers
Recommended Sessions
- Advancement in New Drug Discovery for Treatment of Hepatitis
- Critical Care and Hepatology Nursing
- Epidemiology of Hepatitis
- Hepatitis Care
- Hepatocellular Carcinoma
- Intestinal Rehabilitation
- Liver Cancer
- Liver Diseases Diagnosis
- Liver Fibrosis
- Liver Transplantation and Surgery
- Molecular Biology of Hepatitis A, B, C, D and E Viruses
- Pancreatic Diseases
- Pathophysiology of Hepatitis
- Pediatric Gastroenterology, Hepatology and Nutrition
- Pregnancy and Liver Diseases
- Recent Advances in the Viral Hepatitis C Treatment
- Types of Hepatitis
- Viral Hepatitis Management
Related Journals
Are you interested in
- Advances in Tuberculosis Diagnosis, Treatment, and Prevention - Tuberculosis-2025 (France)
- Asthma - Pulmonary Meet 2025 (France)
- Asthma and Allergy - COPD CONGRESS-2025 (Italy)
- Asthma and COPD - COPD_2025 (Spain)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Cardio Pulmonary Disorders - COPD CONGRESS-2025 (Italy)
- Chronic bronchitis - COPD CONGRESS-2025 (Italy)
- Chronic Bronchitis - Pulmonary Meet 2025 (France)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- Chronic Obstructive Pulmonary Disease - COPD_2025 (Spain)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- Co-Morbidities of COPD - COPD_2025 (Spain)
- Community-based Approaches to TB and Lung Health Awareness - Tuberculosis-2025 (France)
- COPD - Pulmonary Meet 2025 (France)
- COPD and Air Pollution - COPD CONGRESS-2025 (Italy)
- COPD and Cardiovascular Diseases - COPD_2025 (Spain)
- COPD Complications - COPD_2025 (Spain)
- COPD Exacerbations - COPD_2025 (Spain)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Pathogenesis - COPD CONGRESS-2025 (Italy)
- COPD Pathogenesis - COPD_2025 (Spain)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD Therapeutics - COPD_2025 (Spain)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS-2025 (Italy)
- COPD: Sign and Symptoms - COPD_2025 (Spain)
- Cystic Fibrosis - Pulmonary Meet 2025 (France)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Depression and Anxiety in COPD - COPD CONGRESS-2025 (Italy)
- Depression and anxiety in COPD - COPD_2025 (Spain)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Diagnosis and Treatment of COPD - COPD CONGRESS-2025 (Italy)
- Digital Health Technologies for Respiratory Disease Management - Tuberculosis-2025 (France)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS-2025 (Italy)
- Drug Discovery of COPD - COPD_2025 (Spain)
- Early Diagnosis and Biomarkers in Respiratory Diseases - Tuberculosis-2025 (France)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS-2025 (Italy)
- Emerging Respiratory Threats and Pandemic Preparedness - Tuberculosis-2025 (France)
- Emphysema - COPD CONGRESS-2025 (Italy)
- Emphysema - Pulmonary Meet 2025 (France)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Epidemiology of COPD - COPD_2025 (Spain)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Genetic risk factor of COPD - COPD_2025 (Spain)
- Genetics and Susceptibility to Tuberculosis and Lung Diseases - Tuberculosis-2025 (France)
- Global Efforts to Eliminate Tuberculosis by 2030 - Tuberculosis-2025 (France)
- Hospital-acquired Infections and Respiratory Care - Tuberculosis-2025 (France)
- Impact of Smoking and Environmental Factors on Lung Health - Tuberculosis-2025 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2025 (France)
- Interstitial lung disease - Pulmonary Meet 2025 (France)
- Latent Tuberculosis: Diagnosis, Treatment, and Control - Tuberculosis-2025 (France)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD CONGRESS-2025 (Italy)
- Lung Cancer - Pulmonary Meet 2025 (France)
- Lung cancer - COPD_2025 (Spain)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS-2025 (Italy)
- Lung Health: Emerging Trends and Challenges - Tuberculosis-2025 (France)
- Lung problems - Pulmonary Meet 2025 (France)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Lung Transplantation - COPD CONGRESS-2025 (Italy)
- Lung transplantation - Pulmonary Meet 2025 (France)
- Multidrug-Resistant Tuberculosis (MDR-TB) and Novel Therapies - Tuberculosis-2025 (France)
- Neonatal and Maternal Respiratory Health - Tuberculosis-2025 (France)
- Novel Therapies and Drug Development for Tuberculosis - Tuberculosis-2025 (France)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pathophysiology of COPD - COPD_2025 (Spain)
- Pediatric Neonatal Care in COPD - COPD CONGRESS-2025 (Italy)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2025 (Spain)
- Pediatric Pulmonology & Critical care - COPD CONGRESS-2025 (Italy)
- Pediatric Tuberculosis and Respiratory Health - Tuberculosis-2025 (France)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Pleural Diseases - Pulmonary Meet 2025 (France)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2025 (France)
- Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Pulmonary diseases - COPD CONGRESS-2025 (Italy)
- Pulmonary diseases-treatment and therapies - COPD_2025 (Spain)
- Pulmonary Hypertension - Pulmonary Meet 2025 (France)
- Pulmonary Hypertension - COPD_2025 (Spain)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Pulmonary Rehabilitation - COPD CONGRESS-2025 (Italy)
- Pulmonary Rehabilitation - Pulmonary Meet 2025 (France)
- Pulmonary Rehabilitation and Holistic Care for Respiratory Diseases - Tuberculosis-2025 (France)
- Pulmonary vascular disease - Pulmonary Meet 2025 (France)
- Pulmonology - Pulmonary Meet 2025 (France)
- Respiratory and sleep Medicine - COPD CONGRESS-2025 (Italy)
- Respiratory Disorders - Pulmonary Meet 2025 (France)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Infections and Global Public Health Concerns - Tuberculosis-2025 (France)
- Respiratory Infections and Global Public Health Concerns - Tuberculosis-2025 (France)
- Respiratory Tract Infections - COPD CONGRESS-2025 (Italy)
- Respiratory Tract Infections - Pulmonary Meet 2025 (France)
- Role of Artificial Intelligence in Tuberculosis Diagnosis - Tuberculosis-2025 (France)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Self-Management and Prevention of COPD - COPD CONGRESS-2025 (Italy)
- Self-Management and Prevention of COPD - COPD_2025 (Spain)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2025 (France)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Spirometry - COPD CONGRESS-2025 (Italy)
- Stages & Severity on Lung Diseases - COPD CONGRESS-2025 (Italy)
- Tobacco control - COPD CONGRESS-2025 (Italy)
- Tuberculosis - Pulmonary Meet 2025 (France)
- Tuberculosis and HIV Co-infection: Challenges and Treatment - Tuberculosis-2025 (France)
- Tuberculosis Prevention and Global Public Health Strategies - Tuberculosis-2025 (France)
- Types of COPD - COPD CONGRESS-2025 (Italy)
- Types of COPD - COPD_2025 (Spain)